PUNE: The state health department will begin work on its ambitious Maharashtra Institute of Virology (MIV) in Pune from next month. The project aims at strengthening the state’s diagnostic and ...

Xia Xian, a virologist who was formerly a project scientist at the University of California, Los Angeles, has left the United States to take up a position studying highly pathogenic viruses – those ...

A Chinese drug could help manage outbreaks of Nipah and prevent the spread of the deadly virus that has no vaccine or cure, researchers have said. The virus has a fatality rate of up to 75 per cent ...

CAGAYAN DE ORO CITY (PIA) — The Department of Science and Technology (DOST) emphasized the role of the Virology and Vaccine Institute of the Philippines (VIP) in safeguarding the nation’s food ...

The Department of Science and Technology (DOST) is conducting a series of public consultations to draft the implementing rules and regulations (IRR) of Republic Act 12290 or the Virology and Vaccine ...

DOST officials, industry experts and stakeholders from government, academe, research institutions and the private sector pose for a photo during the Visayas leg of the public consultation on the ...

Pune: A three-day international conference on virology and public health, VIROCON 2025, was held in the city between Dec 8 and 10.It was hosted by the Indian Council of Medical Research – National ...

Here's some news for the word nerds out there. Merriam-Webster, the country’s oldest dictionary publisher, is releasing a hefty, new Collegiate edition for the first time in 22 years. “So, the ...

Your Comment article was a welcome admission that the safety measures taken when researching potentially dangerous viruses can, very occasionally, be inadequate (M. Ott et al. Nature 646, 31–34; 2025) ...

Start your coursework in cell and molecular biology and advance from there to virology and the host response to viral infections. Smaller class sizes mean you’ll receive individualized attention and ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in ...

Gilead Sciences has bolted another asset onto the virology engine that powers the company, paying (PDF) Health Hope Pharma $10 million upfront for global rights to a candidate in a limited set of ...